{
    "criteria": [
        {
            "criterion": "AllDocuments",
            "passed": true,
            "reason": "All documents pass."
        },
        {
            "criterion": "QuestionAnswerStringsV2",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "FullyStructured",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ExamStringsV2",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ExamplesStrings",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ExamplesStringsV2",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ListPrefixV2",
            "passed": true,
            "reason": "Text contains ['2', '3', '4', '5', '7', '8', '9', '1', '1', '1', '1', '2', '2', '3', '3', '6', '6', '6', '8', '8', '1', '3', '3', '3', '3', '3', '3', '3', '3', '3', '3', '5', '6', '7', '7', '7', '7', '1', '1']."
        },
        {
            "criterion": "ExamplesMinimalEmbed",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ExamplesSynonymsEmbed",
            "passed": false,
            "reason": "Does not meet criterion."
        },
        {
            "criterion": "ExamplesDiverseEmbed",
            "passed": false,
            "reason": "Does not meet criterion."
        }
    ],
    "doc_id": "6239",
    "text": "For information on treatment of meningitis caused by L. monocytogenes, see Meningitis and Other CNS Infections under Uses.\nAlso see Pediatric Patients: Meningitis Caused by L. monocytogenes, under Dosage and Administration.\nAlso see Adults: Meningitis Caused by L. monocytogenes, under Dosage and Administration.\nAlso see Adults: Meningitis Caused by N. meningitidis, under Dosage and Administration.\n2. Pfizer. Bicillin L-A (penicillin G benzathine) injectable suspension prescribing information. New York, NY; 2016 Jun.\n3. Pfizer. Permapen isoject (penicillin G benzathine) injectable suspension 1,200,000 units for intramuscular use only prescribing information. New York, NY; undated.\n4. Pfizer. Bicillin C-R 900/300 (penicillin G benzathine and penicillin G procaine) injectable suspension for deep IM injection only prescribing information. New York, NY; 2016 Jun.\n5. Pfizer. Bicillin C-R (penicillin G benzathine and penicillin G procaine) injectable suspension disposable syringe for deep IM injection only prescribing information. New York, NY; 2016 Jun.\n7. Pfizer. Penicillin G procaine injectable suspension for deep IM injection only prescribing information. New York, NY; 2016 Oct.\n8. Sandoz. Penicillin G sodium for injection, USP 5 million units prescribing information. Princeton, NJ; 2014 May.\n9. Pfizer. Pfizerpen (penicillin G potassium) for injection prescribing information. Princeton, NJ; 2016 Dec.\n10. Bennett JE, Dolin R, Blaser MK, eds. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015.\n11. Baxter Healthcare Corporation. Penicillin G potassium injection, USP for intravenous use only prescribing information. Deerfield, IL; 2017 Nov.\n12. WG Critical Care. Penicillin G potassium for injection, USP prescribing information. Paramus, NJ; 2013 Feb.\n17. Charles L. Pamplin. Dear healthcare professional letter regarding administration and use of penicillin G benzathine and penicillin G procaine. Bristol, TN: King Pharmaceuticals, Inc; 2004.\n24. Tschudy MM, Arcara KM, eds. The Harriet Lane handbook: a manual for pediatric house officers. 19th ed. Philadelphia, PA: Elsevier Mosby; 2012:902-5.\n25. Penicillin G and penicillin V. In: Briggs GG, Freeman RK, Towers CV et al. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer Health; 2017:1130-32.\n36. Engelkens HJH, Vuzevski VD, Stolz E. Nonvenereal treponematoses in tropical countries. Clin Dermatol. 1999; 19:143-52.\n37. Ayoub EM. Prophylaxis in patients with rheumatic fever: every three or every four weeks? J Pediatr. 1989; 115:89-91. Editorial.\n61. Grayson ML, ed. Kucers' the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. Boca Raton, FL: CRC Press; 2018:.\n63. Neu HC. Penicillins: microbiology, pharmacology, and clinical use. In: Kagan BM, ed. Antimicrobial therapy. 3rd ed. Philadelphia: WB Saunders Company; 1980:20-34.\n64. Mandell GL, Sande MA. Antimicrobial agents: penicillins and cephalosporins. In: Gilman AG, Goodman L, Gilman A, eds. Goodman and Gilman\u2019s the pharmacological basis of therapeutics. 6th ed. New York: Macmillan Publishing Company; 1980:1126-61.\n81. Bergan T. Penicillins. In: Schonfeld H, ed. Antibiotics and chemotherapy. Vol 25. Basel: S. Karger; 1978:1-122.\n88. Selwyn S. The mechanisms and range of activity of penicillins and cephalosporins. In: Selwyn S, ed. The beta-lactam antibiotics: penicillins and cephalosporins in perspective. London: Hodder and Stoughton; 1980:56-90.\n147. Williamson R, Zighelboim S, Tomasz A. Penicillin-binding proteins of penicillin-resistant and penicillin-tolerant Streptococcus pneumoniae. In: Salton M, Shockman GD, eds. \u03b2-Lactam antibiotics: mode of action, new developments, and future prospects. New York: Academic Press; 1981:215-26.\n330. Kaplan JM, McCracken GH, Culbertson MC. Penicillin and erythromycin concentrations in tonsils: relevance to treatment failures in streptococcal pharyngitis. Am J Dis Child. 1974; 127:206-11.\n341. Selwyn S. Applied pharmacology, adverse effects and drug interactions. In: Selwyn S, ed. The beta-lactam antibiotics: penicillins and cephalosporins in perspective. London: Hodder and Stoughton; 1980:91-126.\n348. Giusti DL. A review of the clinical use of antimicrobial agents in patients with renal and hepatic insufficiency: the penicillins. Drug Intell Clin Pharm. 1973; 7:62-74.\n355. Anderson PO. Drugs and breast feeding\u2014a review. Drug Intell Clin Pharm. 1977; 11:208-23.\n361. Dittert LW, Griffen WO, LaPiana JC et al. Pharmacokinetic interpretation of penicillin levels in serum and urine after intravenous administration. Antimicrob Agents Chemother. 1969:42-8.\n364. Greene HF, Burkhart B, Hobby GL. Excretion of penicillin in human milk following parturition. J Obstet Gynecol. 1946; 51:732-3.\n365. Kaplan JM, McCracken GH. Clinical pharmacology of benzathine penicillin G in neonates with regard to its recommended use in congenital syphilis. J Pediatr. 1973; 82:1069-72.\n368. McCracken GH, Ginsberg C, Chrane DF et al. Clinical pharmacology of penicillin in newborn infants. Pediatr Pharmacol Ther. 1973; 82:692-8.\n371. Klein JO, Schaberg MJ, Buntin M et al. Levels of penicillin in serum of newborn infants after single intramuscular doses of benzathine penicillin G. Pediatr Pharmacol Ther. 1973; 82:1065-8.\n374. Matsuda S. Transfer of antibiotics into maternal milk. Biol Res Pregnancy. 1984; 5:57-60.\n599. Ekedahl C, Holm SE, Bergholm AM. Penetration of antibiotics into the normal and diseased maxillary sinus mucosa. Scand J Infect Dis. 1978; 14(Suppl):279-84.\n683. US Army Medical Research Institute of Infectious Diseases. USAMRIID\u2019s medical management of biologic casualties handbook. 8th ed. Fort Detrick, MD: USAMRIID; 2014 Sep.\n713. MacFarlane MD, McCarron MM. Anaphylactic shock and anaphylactoid reaction: analysis of 62 cases. Drug Intell Clin Pharm. 1973; 7:394-405.\n745. Morris JG Jr, Hatheway CL. Botulism in the United States, 1979. J Infect Dis. 1980; 142:302-5.\n772. Back DJ, Breckenridge AM, MacIver M et al. The interaction between ampicillin and oral contraceptive steroids in women. Proc Br Pharmacol Soc. 1981; 280-1.\n778. Mylan. Methotrexate injection prescribing information. Rockford, IL; 2016 Jul.\n1414. Behrman RE, Vaughn VC III, eds. Nelson textbook of pediatrics. 12th ed. Philadelphia: WB Saunders Company: 1983:403-5,619-25,1823.\n1563. Bainbridge CV (Pfipharmecs, New York, NY): Personal communication; 1984 Dec 11."
}